Cell-free DNA is of increasing interest in different fields, such as cancer research, prenatal diagnosis, and the diagnosis of nonmalignant diseases. The quantity of freecirculating DNA in plasma, serum, and other body fluids is usually low and its isolation is still a challenge. Here we evaluate the application of the new commercially available NucleoSpin Plasma XS Kit for the isolation of cell-free DNA from plasma, serum, and cell-free bronchial lavage samples. The NucleoSpin columns proved superior to the QIAamp system in terms of DNA yield, purity, and retrieval of small DNA fragments. The procedure is fast and easy to standardize and might be valuable for laboratories working in the field of CNAPS.
Introduction
Extracellular nucleic acids are present in different body fluids such as plasma, serum, bronchial lavage, and other body fluids and their analysis has gained increasing attention during recent years. 1 The usefulness of the analysis of cell-free DNA has been demonstrated in several fields such as prenatal diagnosis utilizing fetal DNA from maternal plasma 2 and the diagnosis and prognosis of patients with cancer. 3, 4 Additionally, it was shown that the examination of cell-free DNA in patients with nonmalignant diseases can be of value. [5] [6] [7] [8] Because of the small quantity and highly frag-mented nature of cell-free DNA in plasma and serum, it is still a problem to achieve fast, efficient, and reliable isolation. [9] [10] [11] Commercial products for the isolation of DNA from body fluids have predominantly been developed, with a focus on medium-and high-molecular-weight DNA, that is, viral and genomic DNA. Little effort has been spent on fast and efficient commercially available purification systems for the isolation of highly fragmented DNA (approx. 50-300 bp) from body fluids. Thus, many existing products have weaknesses regarding isolation of short DNA fragments from body fluids. Another challenge in the purification of cell-free DNA is the low concentration of the target DNA. Ideally, the purification method should allow for processing reasonable sample amounts and at the same time for elution in a very small volume. The NucleoSpin Plasma XS Kit (MachereyNagel, Düren, Germany) has been developed with a focus on the fast and efficient isolation of low-molecular-weight DNA from plasma and serum. A special emphasis was put on the high recovery of DNA fragments < 200 bp. In addition, the special design of the DNA binding column yields highly concentrated DNA as the elution volume can be as low as 5 μL. Here we describe the evaluation of this system with regard to DNA yield, concentration, purity, applicability in PCR, size of recovered fragments, and time and ease of preparation.
Materials and Methods
Blood plasma was prepared from fresh or frozen human EDTA blood samples by centrifugation for 10 min at 2000 × g. Plasma was removed from the cell pellet, taking care to avoid leukocyte carryover. Some plasma samples were frozen and stored for several days to weeks at −80
• C. Prior to DNA isolation, plasma samples were re-centrifuged for 3 min at 11,000 × g to remove any particulate matter, and the cleared supernatant was further processed. The isolation of DNA from cellfree plasma samples was performed essentially according to the manufacturer's instructions. The kit utilizes the benefits of a new column type which directs the sample to a very small silica membrane. This allows for elution of DNA in 5-30 μL. In detail, 200 μL (rapid protocol) or 240 μL (high-sensitivity protocol) plasma sample was mixed with 1.5 volume binding buffer. The mixture was applied to the spin column and spun for 30 sec at 11,000 × g. After two subsequent washing steps (each with 500 μL wash buffer; 30 sec. 11,000 × g for the first wash and 3 min 11,000 × g for the second wash), the DNA was eluted with 20 μL (rapid protocol) and-for some experiments-additionally heat-treated for 8 min at 90
• C (high-sensitivity protocol). No proteinase K treatment was utilized within the NucleoSpin Plasma XS experiments described here. The isolated DNA was quantified either with PicoGreen fluorescent dye, or a quan- titative real-time PCR with TaqMan probe for a 135-bp single-copy gene (human endogenous retrovirus). 12 Alternatively, some of the samples were quantified using a real-time PCR with SYBR Green and an 81-bp single-copy beta globin target. For this assay we used the primers 5 -CAACCTCAAACAGACACCAT-3 and 5 -CACGTTCACCTTGCCCCACA-3 according to the method of Jung et al. with slight modification.
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Results
The standard sample volume applied onto the NucleoSpin Plasma XS columns is 200 μL and 240 μL. Because of the frequent request to process large plasma volumes, we first investigated whether multiple column loadings resulted in increased DNA yield. Five independent plasma samples were subjected to DNA isolation according to the NucleoSpin Plasma XS rapid protocol with one to four column loadings (Fig. 1) . As expected, DNA yield varied considerably between different plasma samples. Further, for all five plasma samplesindependent of their DNA content-DNA yield increased from one to three column loadings. Thus, if a higher sensitivity and DNA yield is required, repeated loading and processing of a plasma sample up to 600 μL is an option.
To investigate the DNA purity and the absence of inhibitors, DNA was isolated from 240 μL plasma according to the high-sensitivity protocol. For comparison, DNA was isolated from an identical plasma aliquot with the QIAamp DNA Blood Mini Kit. One to eight microliters of DNA eluate were used as template in qPCR with a final reaction volume of 20 μL (Fig. 2) . For the NucleoSpin DNA, the PCR signal increased with increasing eluate input as expected for inhibitor-free DNA. For QIAamp DNA a reduced PCR signal was obtained with 4-8 μL eluate input, indicating significant PCR inhibition. In order to investigate the recovery rate of highly fragmented DNA, plasma was spiked with 50-, 100-, 150-, 250-, and 1000-bp DNA fragments and subjected to DNA purification with NucleoSpin Plasma XS and QIAamp DNA Blood Mini Kit. All fragment sizes were recovered with the NucleoSpin kit whereas the QIAamp kit failed to recover the 50-bp spike and achieved an overall lower spike concentration in the eluate (Fig. 3) .
Finally, the applicability of the purification system was evaluated with clinical samples. Plasma, serum, and bronchial lavage samples of 200-240 μL each from 33 patients with lung tumors and 27 patients with nonmalignant lung disease were subjected to the NucleoSpin Plasma XS procedure and the DNA was amplified in a real-time quantitative PCR using ERV as a target sequence. DNA from all serum samples was amplifiable, as well as all DNA samples isolated from all cell-free bronchial lavage supernatants. Only one of 60 plasma samples yielded a negative result in the qPCR (see the chapter by Schmidt et al. in this volume).
The two most often cited commercial kits used for the isolation of DNA from plasma and serum are the QIAamp DNA Blood Mini Kit (Qiagen) and the HighPure PCR Template Preparation kit (Roche). Comparing these kits with the NucleoSpin Plasma XS method, we showed that the NucleoSpin kit has fewer steps and a shorter handling time per preparation (data not shown).
Discussion
The investigated DNA purification system allows for the purification of DNA from plasma, serum, and cell-free bronchial lavage, yielding reliable results. The DNA yield and concentration obtained from 200-240-μL samples is sufficient for most applications. In agreement with previously published results, the plasma DNA concentration is influenced by a variety of different factors, varies considerably among plasma samples, and falls typically in the range of 0.1-30 ng DNA per milliliter plasma. 1 The improved design of the NucleoSpin columns and the possibility of eluting DNA in a very small volume (5-30 μL) allows for the examination of plasma samples containing only miniscule amounts of DNA.
The DNA used in the above-described experiments was isolated using the instructions of the manufacturer, that is, no proteinase treatment was involved. Preliminary experiments demonstrated that the treatment of plasma samples with proteinase (10 min at 37
• C) yielded an increase of the qPCR signal (i.e., a 0.5 to 1.5 lower Ct value) for some plasma samples, indicating a higher yield (data not shown). An increased concentration of antibody-bound circulatory cell-free DNA has been demonstrated in patients with rheumatoid arthritis. 14 So far it is unknown whether this DNA-protein association can be detected in other patients as well. The observation that we demonstrated a lower Ct value (i.e., an increased quantity) in some plasma DNA samples led us to consider including a proteinase digestion step for the ongoing development of the columns (the currently available kit contains proteinase K as an optional treatment step).
The dominating downstream application of extracted plasma DNA is analysis with quantitative real-time PCR. Because the amount of isolated DNA from plasma is usually very low, a high purity of the eluted DNA and the absence of PCR inhibitors is mandatory. DNA eluted with the NucleoSpin Plasma XS Kit did not show any PCR inhibition, even when the eluate made up 40% of the final PCR volume. On the contrary, DNA purified with the QIAamp DNA Blood mini kit showed considerable PCR inhibition.
To summarize, the NucleoSpin columns proved superior to the QIAamp system in terms of DNA yield, purity, and retrieval of small DNA fragments. The more efficient isolation of small DNA fragments contributes to the higher DNA yield determined by qPCR. The procedure is fast and easy to standardize and highly valuable for laboratories working in the field of circulating nucleic acids in plasma and serum.
